DCGI approves commercial launch of low cost Covid-19 test ‘Feluda’

New Delhi: The Drugs Controller General of India has approved the commercial launch of ‘Feluda‘, the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of Scientific and Industrial Research (CSIR) said on Saturday. This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the …

Read moreDCGI approves commercial launch of low cost Covid-19 test ‘Feluda’